Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants .
Not Applicable
Completed
- Conditions
- social anxiety disordersocial phobiaMental Health - Anxiety
- Registration Number
- ACTRN12608000363381
- Lead Sponsor
- niversity of Bristol
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Diagnostic and Statistical Manual version 4 (DSM-IV) diagnosis of social anxiety disorder
Clinical Global Impressions-Improvement (CGI-I) score of 1 or 2
Non-smokers
Exclusion Criteria
Exclusion criteria were neurological / other serious medical illness, other primary DSM-IV Axis I diagnoses, dopaminergic medicines in the six months preceding the enrolment, history of adverse reaction to sulpiride or pramipexole, pregnancy, lactation or inadequate contraceptive methods.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method